A citation-based method for searching scientific literature

G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
Times Cited: 99







List of co-cited articles
1339 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
94
43

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
T A Zesiewicz, P E Greenstein, K L Sullivan, L Wecker, A Miller, I Jahan, R Chen, S L Perlman. Neurology 2012
65
46

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
917
26

Intensive coordinative training improves motor performance in degenerative cerebellar disease.
W Ilg, M Synofzik, D Brötz, S Burkard, M A Giese, L Schöls. Neurology 2009
141
23


Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia.
Joy T Walter, Karina Alviña, Mary D Womack, Carolyn Chevez, Kamran Khodakhah. Nat Neurosci 2006
270
19

Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3.
Vikram G Shakkottai, Maria do Carmo Costa, James M Dell'Orco, Ananthakrishnan Sankaranarayanan, Heike Wulff, Henry L Paulson. J Neurosci 2011
124
18

Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2.
Adebimpe W Kasumu, Charlotte Hougaard, Frederik Rode, Thomas A Jacobsen, Jean Marc Sabatier, Birgitte L Eriksen, Dorte Strøbæk, Xia Liang, Polina Egorova, Dasha Vorontsova,[...]. Chem Biol 2012
79
22

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.
Ludger Schöls, Peter Bauer, Thorsten Schmidt, Thorsten Schulte, Olaf Riess. Lancet Neurol 2004
649
16

Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.
Ichiro Miyai, Mizuki Ito, Noriaki Hattori, Masahito Mihara, Megumi Hatakenaka, Hajime Yagura, Gen Sobue, Masatoyo Nishizawa. Neurorehabil Neural Repair 2012
93
17

KCa channels as therapeutic targets in episodic ataxia type-2.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
72
20

Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole.
Ying-Jun Cao, John C Dreixler, Jonathan J Couey, Khaled M Houamed. Eur J Pharmacol 2002
87
17

Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
Jing Liu, Tie-Shan Tang, Huiping Tu, Omar Nelson, Emily Herndon, Duong P Huynh, Stefan M Pulst, Ilya Bezprozvanny. J Neurosci 2009
184
13

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
877
13

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
H Jacobi, P Bauer, P Giunti, R Labrum, M G Sweeney, P Charles, A Dürr, C Marelli, C Globas, C Linnemann,[...]. Neurology 2011
120
13

Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
Nicholas A Di Prospero, Angela Baker, Neal Jeffries, Kenneth H Fischbeck. Lancet Neurol 2007
186
12

Responsiveness of different rating instruments in spinocerebellar ataxia patients.
T Schmitz-Hübsch, R Fimmers, M Rakowicz, R Rola, E Zdzienicka, R Fancellu, C Mariotti, C Linnemann, L Schöls, D Timmann,[...]. Neurology 2010
91
13

Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.
Xi Chen, Tie-Shan Tang, Huiping Tu, Omar Nelson, Mark Pook, Robert Hammer, Nobuyuki Nukina, Ilya Bezprozvanny. J Neurosci 2008
151
12

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
109
12

Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice.
Zhenyu Gao, Boyan Todorov, Curtis F Barrett, Stijn van Dorp, Michel D Ferrari, Arn M J M van den Maagdenberg, Chris I De Zeeuw, Freek E Hoebeek. J Neurosci 2012
61
19

Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
88
13

The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
111
11

Long-term effects of coordinative training in degenerative cerebellar disease.
Winfried Ilg, Doris Brötz, Susanne Burkard, Martin A Giese, Ludger Schöls, Matthis Synofzik. Mov Disord 2010
77
14

A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
David R Lynch, Susan L Perlman, Thomas Meier. Arch Neurol 2010
120
11

Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.
M I Botez, T Botez-Marquard, R Elie, O L Pedraza, K Goyette, R Lalonde. J Neurol Neurosurg Psychiatry 1996
60
18

Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia.
Vikram G Shakkottai, Chin-hua Chou, Salvatore Oddo, Claudia A Sailer, Hans-Günther Knaus, George A Gutman, Michael E Barish, Frank M LaFerla, K George Chandy. J Clin Invest 2004
74
14


CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
10

A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.
Jonas Alex Morales Saute, Raphael Machado de Castilhos, Thais Lampert Monte, Artur Francisco Schumacher-Schuh, Karina Carvalho Donis, Rui D'Ávila, Gabriele Nunes Souza, Aline Dutra Russo, Gabriel Vasata Furtado, Tailise Conte Gheno,[...]. Mov Disord 2014
44
22

Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
James M Dell'Orco, Aaron H Wasserman, Ravi Chopra, Melissa A C Ingram, Yuan-Shih Hu, Vikrant Singh, Heike Wulff, Puneet Opal, Harry T Orr, Vikram G Shakkottai. J Neurosci 2015
60
16

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Luis Ruano, Claudia Melo, M Carolina Silva, Paula Coutinho. Neuroepidemiology 2014
246
10

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
T Schmitz-Hübsch, M Coudert, P Bauer, P Giunti, C Globas, L Baliko, A Filla, C Mariotti, M Rakowicz, P Charles,[...]. Neurology 2008
167
9


Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.
S M Pulst, A Nechiporuk, T Nechiporuk, S Gispert, X N Chen, I Lopes-Cendes, S Pearlman, S Starkman, G Orozco-Diaz, A Lunkes,[...]. Nat Genet 1996
870
9

Occupational therapy in spinocerebellar ataxia type 3: an open-label trial.
R C R Silva, J A M Saute, A C F Silva, A C O Coutinho, M L Saraiva-Pereira, L B Jardim. Braz J Med Biol Res 2010
21
42

Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Ananthakrishnan Sankaranarayanan, Girija Raman, Christoph Busch, Tim Schultz, Pavel I Zimin, Joachim Hoyer, Ralf Köhler, Heike Wulff. Mol Pharmacol 2009
137
9

Treatment of spinocerebellar ataxia with buspirone.
Mitra Assadi, Joseph V Campellone, Christopher G Janson, J Jon Veloski, Robert J Schwartzman, Paola Leone. J Neurol Sci 2007
20
45

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
Haibin Xia, Qinwen Mao, Steven L Eliason, Scott Q Harper, Inês H Martins, Harry T Orr, Henry L Paulson, Linda Yang, Robert M Kotin, Beverly L Davidson. Nat Med 2004
485
9

Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial.
Luis Velázquez-Pérez, Jorge Rodríguez-Chanfrau, Julio Cesar García-Rodríguez, Gilberto Sánchez-Cruz, Raúl Aguilera-Rodríguez, Roberto Rodríguez-Labrada, Julio Cesar Rodríguez-Díaz, Nalia Canales-Ochoa, Dennis Almaguer Gotay, Luis E Almaguer Mederos,[...]. Neurochem Res 2011
18
50

Small-conductance Ca2+-activated K+ channels: form and function.
John P Adelman, James Maylie, Pankaj Sah. Annu Rev Physiol 2012
281
9

Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Raphael Hourez, Laurent Servais, David Orduz, David Gall, Isabelle Millard, Alban de Kerchove d'Exaerde, Guy Cheron, Harry T Orr, Massimo Pandolfo, Serge N Schiffmann. J Neurosci 2011
86
10

Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials.
Jonas Alex Morales Saute, Karina Carvalho Donis, Carmen Serrano-Munuera, David Genis, Luís Torres Ramirez, Pilar Mazzetti, Luis Velázquez Pérez, Pilar Latorre, Jorge Sequeiros, Antoni Matilla-Dueñas,[...]. Cerebellum 2012
71
12

Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.
Philipp Koch, Peter Breuer, Michael Peitz, Johannes Jungverdorben, Jaideep Kesavan, Daniel Poppe, Jonas Doerr, Julia Ladewig, Jerome Mertens, Thomas Tüting,[...]. Nature 2011
224
9

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. Lancet Neurol 2015
111
9

In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.
Polina A Egorova, Olga A Zakharova, Olga L Vlasova, Ilya B Bezprozvanny. J Neurophysiol 2016
37
24

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Daniel R Scoles, Pratap Meera, Matthew D Schneider, Sharan Paul, Warunee Dansithong, Karla P Figueroa, Gene Hung, Frank Rigo, C Frank Bennett, Thomas S Otis,[...]. Nature 2017
144
9

Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up.
Mercè Pineda, Javier Arpa, Raquel Montero, Asunción Aracil, Francisco Domínguez, Marta Galván, Anna Mas, Loreto Martorell, Cristina Sierra, Nuria Brandi,[...]. Eur J Paediatr Neurol 2008
72
11

Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy.
J M Cooper, L V P Korlipara, P E Hart, J L Bradley, A H V Schapira. Eur J Neurol 2008
103
8

The spinocerebellar ataxias.
Henry L Paulson. J Neuroophthalmol 2009
108
8

SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.
T Schmitz-Hübsch, P Giunti, D A Stephenson, C Globas, L Baliko, F Saccà, C Mariotti, M Rakowicz, S Szymanski, J Infante,[...]. Neurology 2008
79
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.